184 related articles for article (PubMed ID: 16596776)
1. Structural requirements for cannabinoid receptor probes.
Thakur GA; Nikas SP; Li C; Makriyannis A
Handb Exp Pharmacol; 2005; (168):209-46. PubMed ID: 16596776
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptors and their ligands: ligand-ligand and ligand-receptor modeling approaches.
Reggio PH
Handb Exp Pharmacol; 2005; (168):247-81. PubMed ID: 16596777
[TBL] [Abstract][Full Text] [Related]
3. Indoles and related compounds as cannabinoid ligands.
Manera C; Tuccinardi T; Martinelli A
Mini Rev Med Chem; 2008 Apr; 8(4):370-87. PubMed ID: 18473928
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological actions of cannabinoids.
Pertwee RG
Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
[TBL] [Abstract][Full Text] [Related]
5. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.
De Petrocellis L; Di Marzo V
J Neuroimmune Pharmacol; 2010 Mar; 5(1):103-21. PubMed ID: 19847654
[TBL] [Abstract][Full Text] [Related]
6. Synthetic cannabinoids: analysis and metabolites.
Elsohly MA; Gul W; Wanas AS; Radwan MM
Life Sci; 2014 Feb; 97(1):78-90. PubMed ID: 24412391
[TBL] [Abstract][Full Text] [Related]
7. Molecular probes for the cannabinoid receptors.
Khanolkar AD; Palmer SL; Makriyannis A
Chem Phys Lipids; 2000 Nov; 108(1-2):37-52. PubMed ID: 11106781
[TBL] [Abstract][Full Text] [Related]
8. Cannabinergic ligands.
Palmer SL; Thakur GA; Makriyannis A
Chem Phys Lipids; 2002 Dec; 121(1-2):3-19. PubMed ID: 12505686
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid 1 (CB1) receptor--pharmacology, role in pain and recent developments in emerging CB1 agonists.
Talwar R; Potluri VK
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):536-44. PubMed ID: 21631407
[TBL] [Abstract][Full Text] [Related]
10. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
Klegeris A; Bissonnette CJ; McGeer PL
Br J Pharmacol; 2003 Jun; 139(4):775-86. PubMed ID: 12813001
[TBL] [Abstract][Full Text] [Related]
11. The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots.
Woelkart K; Xu W; Pei Y; Makriyannis A; Picone RP; Bauer R
Planta Med; 2005 Aug; 71(8):701-5. PubMed ID: 16142631
[TBL] [Abstract][Full Text] [Related]
12. Methods for the synthesis of cannabinergic ligands.
Thakur GA; Nikas SP; Duclos RI; Makriyannis A
Methods Mol Med; 2006; 123():113-48. PubMed ID: 16506405
[TBL] [Abstract][Full Text] [Related]
13. Targeting the cannabinoid system for pain relief?
Chiou LC; Hu SS; Ho YC
Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672
[TBL] [Abstract][Full Text] [Related]
14. Oxa-adamantyl cannabinoids.
Ho TC; Tius MA; Nikas SP; Tran NK; Tong F; Zhou H; Zvonok N; Makriyannis A
Bioorg Med Chem Lett; 2021 Apr; 38():127882. PubMed ID: 33636308
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of several structural analogs of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.
Suhara Y; Oka S; Kittaka A; Takayama H; Waku K; Sugiura T
Bioorg Med Chem; 2007 Jan; 15(2):854-67. PubMed ID: 17110113
[TBL] [Abstract][Full Text] [Related]
16. Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions.
Darmani NA
Methods Mol Med; 2006; 123():169-89. PubMed ID: 16506408
[TBL] [Abstract][Full Text] [Related]
17. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors.
Reggio PH
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):143-60. PubMed ID: 12052032
[TBL] [Abstract][Full Text] [Related]
19. Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands.
Poso A; Huffman JW
Br J Pharmacol; 2008 Jan; 153(2):335-46. PubMed ID: 17982473
[TBL] [Abstract][Full Text] [Related]
20. CB1 and CB2 cannabinoid receptor binding studies based on modeling and mutagenesis approaches.
Ortega-Gutiérrez S; López-Rodríguez ML
Mini Rev Med Chem; 2005 Jul; 5(7):651-8. PubMed ID: 16026311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
